Sionna Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Sionna Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Sionna Therapeutics Inc.
Rating: 1.10625
Author: Trendlyne DVM scores

about

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis tran...

20.43 -0.51 (-2.44%)

181.40% Gain from 52W Low

51,638

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.5 / 100

Technically Neutral

36.8 / 100

No estimates available

Sionna Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sionna Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis tran...

181.40% Gain from 52W Low

SWOT Analysis

Sionna Therapeutics Inc. Live Price Chart